Vishal Malkan of malkansview.com suggests buying Lupin with a target of Rs 1000-1020 and Ranbaxy Laboratories with a target of Rs 520.
first published: Jan 6, 2014 08:41 am
A collection of the most-viewed Moneycontrol videos.
Nifty Upmove Hinges On Quarterly Earnings; Will LG Electronics See A Listing Pop?|Opening Bell Live
Live: Nifty snaps 2-day winning streak but rebounds from day's low | Closing Bell | 4K
Sridhar Vembu on Zoho, Arattai. Swadeshi Tech, AI, and India’s Digital Future | Exclusive Interview
Nifty Rebound At Risk As U.S.-China Trade Wars Flare Up?|Diwali Dhamaka Stock Bets|Opening Bell Live
You are already a Moneycontrol Pro user.